Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C

Published:2015-01-24 Issue:2 Volume:30 Page:321-328
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Honda Takashi¹,Ishigami Masatoshi¹,Masuda Hiroko¹,Ishizu Yoji¹,Kuzuya Teiji¹,Hayashi Kazuhiko¹,Itoh Akihiro¹,Hirooka Yoshiki¹,Nakano Isao¹,Ishikawa Tetsuya¹,Urano Fumihiro²,Yoshioka Kentaro³,Toyoda Hidenori⁴,Kumada Takashi⁴,Katano Yoshiaki⁵,Goto Hidemi¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Nagoya University Graduate School of Medicine; Nagoya Japan

2. Department of Gastroenterology; Toyohashi Municipal Hospital; Toyohashi Japan

3. Division of Liver and Biliary Diseases; Department of Internal Medicine; Fujita Health University; Toyoake Japan

4. Department of Gastroenterology; Ogaki Municipal Hospital; Ogaki Japan

5. Department of Gastroenterology; Banbuntane Hotokukai Hospital; Fujita Health University; School of Medicine; Nagoya Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12703/fullpdf

Reference46 articles.

1. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future;Yoshizawa;Oncology,2002

2. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy;Marcellin;Ann. Intern. Med.,1997

3. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy;Shiratori;Ann. Intern. Med.,2000

4. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C;Lai;Gastroenterology,1996

5. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group;McHutchison;N. Engl. J. Med.,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies;Scientific Reports;2023-03-01

2. Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older;JGH Open;2020-12-18

3. Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma;Medicine;2020-10-02

4. Direct-acting antivirals and interferon-based therapy on hepatocellular carcinoma risk in chronic hepatitis-C patients;Future Oncology;2020-04

5. The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?;Molecular Cancer Therapeutics;2019-07